Peer Reviewed



A young woman presenting with recurrent episodes of uterine bleeding due to an extensive uterine arteriovenous malformation was treated with two sessions of uterine artery embolization. Further bleeding was managed with a combination of gonadotropin-releasing hormone and depot medroxyprogesterone acetate. The patient remains asymptomatic with a significant decrease in uterine and pelvic vascularity at one year follow-up.

These drugs may decrease the need for repeat embolization.


Arteriovenous malformation, uterine artery embolization, gonadotropin-releasing hormone agonist, depot medroxyprogesterone acetate

Total Pages


Financial Disclosure

The authors report no conflict of interest.


Copyright © 2014 Padma Krishnaswamy, Indushekar Subbanna, Gayatri Devi Sivasambu, and Urvashi Thukral

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.